Cargando…
Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by several pathologies including oxidative stress, apoptosis, neuroinflammation, and glutamate toxicity. Although multiple reports suggest that ischemia and hypoxia in the spinal cord plays a pivotal role in...
Autores principales: | Tada, Satoru, Okuno, Tatsusada, Shimizu, Mikito, Sakai, Yoshiki, Sumi-Akamaru, Hisae, Kinoshita, Makoto, Yamashita, Kazuya, Sanda, Eri, Choong, Chi-Jing, Namba, Akiko, Sasaki, Tsutomu, Koda, Toru, Takata, Kazushiro, Miyagawa, Shigeru, Sawa, Yoshiki, Nakatsuji, Yuji, Mochizuki, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437213/ https://www.ncbi.nlm.nih.gov/pubmed/30918303 http://dx.doi.org/10.1038/s41598-019-41771-4 |
Ejemplares similares
-
A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
por: Fukushima, Satsuki, et al.
Publicado: (2015) -
Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner
por: Honorat, Josephe A., et al.
Publicado: (2017) -
Innovative therapeutic strategy using prostaglandin I(2) agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension
por: Kanaya, Tomomitsu, et al.
Publicado: (2021) -
Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase
por: Koda, Toru, et al.
Publicado: (2020) -
A novel prostaglandin I(2) agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
por: Motegi, Satoko, et al.
Publicado: (2022)